Literature DB >> 17280714

Biomechanical and biochemical characteristics of a human fibroblast-produced and remodeled matrix.

Jan-Eric W Ahlfors1, Kristen L Billiar.   

Abstract

We report on a culture method for the rapid production of a strong and thick natural matrix by human cells for tissue engineering applications. Dermal fibroblasts were cultured for three weeks at high density on porous substrates in serum-containing or chemically defined media. The mechanical and biochemical properties of the resulting cell-derived matrix (CDM) were compared to those of standard fibroblast-populated collagen and fibrin gels and native human skin. We found that the ultimate tensile strength of CDM cultured in our chemically defined media (313+/-8.7 kPa) is significantly greater than for collagen gels (168+/-39.3 kPa), fibrin gels (133+/-8.0 kPa) and CDM cultured with serum (223+/-9.0 kPa), but less than native skin (713+/-55.2 kPa). In addition to the biomechanics, this *CDM is also biochemically more similar to native skin than the collagen and fibrin gels in terms of all parameters measured. As *CDM is produced by human cells in a chemically defined culture medium and is mechanically robust, it may be a viable living tissue equivalent for many connective tissue replacement applications requiring initial mechanical stability yet a high degree of biocompatibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280714     DOI: 10.1016/j.biomaterials.2006.12.030

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  27 in total

1.  The differential regulation of cell motile activity through matrix stiffness and porosity in three dimensional collagen matrices.

Authors:  Miguel Miron-Mendoza; Joachim Seemann; Frederick Grinnell
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

2.  Alterations in the content and physiological role of sphingomyelin in plasma membranes of cells cultured in three-dimensional matrix.

Authors:  Teodora Lupanova; Nadezhda Stefanova; Diana Petkova; Galya Staneva; Albena Jordanova; Kamen Koumanov; Roumen Pankov; Albena Momchilova
Journal:  Mol Cell Biochem       Date:  2010-02-23       Impact factor: 3.396

3.  Collagen fibril flow and tissue translocation coupled to fibroblast migration in 3D collagen matrices.

Authors:  Miguel Miron-Mendoza; Joachim Seemann; Frederick Grinnell
Journal:  Mol Biol Cell       Date:  2008-03-05       Impact factor: 4.138

Review 4.  Fibroblasts and the ground they walk on.

Authors:  Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2013-11

Review 5.  A review of tissue-engineered skin bioconstructs available for skin reconstruction.

Authors:  Rostislav V Shevchenko; Stuart L James; S Elizabeth James
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

6.  Engineered vascular tissue fabricated from aggregated smooth muscle cells.

Authors:  Tracy A Gwyther; Jason Z Hu; Alexander G Christakis; Jeremy K Skorinko; Sharon M Shaw; Kristen L Billiar; Marsha W Rolle
Journal:  Cells Tissues Organs       Date:  2011-01-19       Impact factor: 2.481

7.  Assembly of Tissue-Engineered Blood Vessels with Spatially Controlled Heterogeneities.

Authors:  Hannah A Strobel; Tracy A Hookway; Marco Piola; Gianfranco Beniamino Fiore; Monica Soncini; Eben Alsberg; Marsha W Rolle
Journal:  Tissue Eng Part A       Date:  2018-08-20       Impact factor: 3.845

8.  Mechanoregulation of valvular interstitial cell phenotype in the third dimension.

Authors:  Mehmet H Kural; Kristen L Billiar
Journal:  Biomaterials       Date:  2013-11-07       Impact factor: 12.479

9.  Highly Aligned Nanofibrous Scaffold Derived from Decellularized Human Fibroblasts.

Authors:  Qi Xing; Caleb Vogt; Kam W Leong; Feng Zhao
Journal:  Adv Funct Mater       Date:  2014-05-28       Impact factor: 18.808

10.  Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue.

Authors:  Zeeshan H Syedain; Jason Bjork; Lillian Sando; Robert T Tranquillo
Journal:  Biomaterials       Date:  2009-09-25       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.